Enanta Pharmaceuticals, Inc. (ENTA)

NASDAQ: ENTA · Real-Time Price · USD

14.15

+0.07 (0.50%)

At close: Aug 26, 2026, 4:00 PM EDT

14.15

0.00 (0.00%)

After-hours: Aug 26, 2026, 7:30 PM EDT

Enanta Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Operating Revenue	65.26	65.32	67.64	79.2	86.16	97.07
Revenue	65.26	65.32	67.64	79.2	86.16	97.07
Revenue Growth	0.70%	-3.42%	-14.61%	-8.07%	-11.24%	-20.74%
Gross Profit	65.26	65.32	67.64	79.2	86.16	97.07
Selling, General & Admin	37.75	43.93	57.85	52.89	45.48	32.54
Research & Development	86.24	106.74	131.48	163.52	164.52	174.11
Operating Expenses	123.99	150.67	189.33	216.41	210	206.65
Operating Income	-58.73	-85.35	-121.69	-137.21	-123.84	-109.57
Interest Expense	-12.92	-7.68	-10.94	-5.15	-	-
Interest & Investment Income	7.85	9.95	13.63	8.5	2.74	2.02
Other Non Operating Income (Expenses)	0.04	0.04	0.07	-	0.08	-0.03
EBT Excluding Unusual Items	-63.76	-83.05	-118.93	-133.85	-121.02	-107.58
Gain (Loss) on Sale of Investments	0.63	-0.5	1.14	2.86	-1.17	-
Pretax Income	-63.13	-83.55	-117.79	-131	-122.19	-107.58
Income Tax Expense	0.1	-1.66	-1.74	2.82	-0.43	-28.58
Net Income	-63.23	-81.89	-116.05	-133.82	-121.76	-79
Net Income to Common	-63.23	-81.89	-116.05	-133.82	-121.76	-79
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	27	21	21	21	21	20
Shares Outstanding (Diluted)	27	21	21	21	21	20
Shares Change	27.12%	0.85%	0.90%	1.78%	2.14%	1.16%
EPS (Basic)	-2.34	-3.84	-5.48	-6.38	-5.91	-3.92
EPS (Diluted)	-2.34	-3.84	-5.48	-6.38	-5.91	-3.92
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Free Cash Flow	-36.94	-32.17	-96.71	-112.21	-86.91	-70.75
Free Cash Flow Per Share	-1.36	-1.51	-4.57	-5.35	-4.22	-3.51
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-89.99%	-130.66%	-179.92%	-173.23%	-143.74%	-112.88%
Profit Margin	-96.89%	-125.36%	-171.58%	-168.95%	-141.31%	-81.38%
Free Cash Flow Margin	-56.61%	-49.24%	-142.99%	-141.67%	-100.87%	-72.88%
EBITDA	-53.82	-80.76	-119.36	-134.84	-120.87	-106.24
EBITDA Margin	-82.47%	-123.63%	-176.47%	-170.24%	-140.29%	-109.44%
D&A For EBITDA	4.91	4.59	2.34	2.37	2.97	3.33
EBIT	-58.73	-85.35	-121.69	-137.21	-123.84	-109.57
EBIT Margin	-89.99%	-130.66%	-179.92%	-173.23%	-143.74%	-112.88%
Revenue as Reported	65.26	65.32	67.64	79.2	86.16	97.07

SEC Filings: 10-K · 10-Q